2015 Annual Report and Notice of AGM

RNS Number : 9972R

Hutchison China Meditech Limited

15 March 2016

 

2015 Annual Report and

Notice of Annual General Meeting

London: Tuesday, March 15, 2016: Hutchison China MediTech Limited ("Chi-Med") (AIM:HCM) today announces that its 2015 Annual Report together with the Notice of Annual General Meeting and the Form of Proxy have been posted to shareholders.  The documents can be accessed from the website of Chi-Med (www.chi-med.com).

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone:     [phone]
Panmure Gordon (UK) Limited	Telephone:     [phone]
Richard Gray Andrew Potts
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone:     [phone] Mobile:           [phone] Mobile:           [phone]

 

Notes to Editors

About Chi-Med

Chi-Med is a China-based, globally-focused healthcare group which researches, develops, manufactures and sells pharmaceuticals and health-related consumer products.  Its Innovation Platform focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market.  Its Commercial Platform manufactures, markets and distributes prescription drugs and consumer health products in China.

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited (SEHK: 0001).  For more information, please visit: www.chi-med.com.

 

END

 

 

MSCBBGDXIXBBGLS